PetMed Historical Cash Flow

PETS Stock  USD 4.64  0.06  1.31%   
Analysis of PetMed Express cash flow over time is an excellent tool to project PetMed Express future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Operating Activities of 4.1 M or End Period Cash Flow of 47.6 M as it is a great indicator of PetMed Express ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining PetMed Express latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PetMed Express is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

About PetMed Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in PetMed balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which PetMed's non-liquid assets can be easily converted into cash.

PetMed Express Cash Flow Chart

At this time, PetMed Express' Begin Period Cash Flow is comparatively stable compared to the past year. Depreciation is likely to gain to about 7.4 M in 2024, despite the fact that Change In Cash is likely to grow to (46.4 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by PetMed Express to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of PetMed Express operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from PetMed Express' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into PetMed Express current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.At this time, PetMed Express' Begin Period Cash Flow is comparatively stable compared to the past year. Depreciation is likely to gain to about 7.4 M in 2024, despite the fact that Change In Cash is likely to grow to (46.4 M).
 2021 2022 2023 2024 (projected)
Capital Expenditures1.8M5.3M4.5M2.7M
Other Non Cash Items165K214K324K261.8K

PetMed Express cash flow statement Correlations

0.290.20.61-0.14-0.240.460.13-0.060.05-0.36-0.05-0.09-0.040.18-0.440.140.630.25
0.290.760.38-0.37-0.710.20.050.780.270.01-0.480.45-0.630.69-0.150.80.380.37
0.20.760.440.12-0.280.03-0.230.790.620.22-0.020.13-0.180.23-0.290.710.30.61
0.610.380.440.0-0.090.370.23-0.040.240.50.18-0.040.04-0.02-0.250.410.470.58
-0.14-0.370.120.00.74-0.4-0.08-0.090.790.230.82-0.260.85-0.560.09-0.16-0.390.21
-0.24-0.71-0.28-0.090.74-0.2-0.04-0.510.290.290.9-0.640.93-0.910.02-0.24-0.320.06
0.460.20.030.37-0.4-0.2-0.03-0.17-0.3-0.07-0.21-0.02-0.240.04-0.070.290.720.29
0.130.05-0.230.23-0.08-0.04-0.03-0.02-0.050.140.07-0.05-0.020.1-0.050.09-0.080.1
-0.060.780.79-0.04-0.09-0.51-0.17-0.020.42-0.08-0.340.3-0.470.53-0.190.610.070.31
0.050.270.620.240.790.29-0.3-0.050.420.230.520.040.46-0.120.00.33-0.170.44
-0.360.010.220.50.230.29-0.070.14-0.080.230.36-0.090.23-0.360.120.27-0.20.4
-0.05-0.48-0.020.180.820.9-0.210.07-0.340.520.36-0.470.93-0.840.05-0.09-0.190.28
-0.090.450.13-0.04-0.26-0.64-0.02-0.050.30.04-0.09-0.47-0.470.70.70.04-0.07-0.31
-0.04-0.63-0.180.040.850.93-0.24-0.02-0.470.460.230.93-0.47-0.810.08-0.28-0.350.05
0.180.690.23-0.02-0.56-0.910.040.10.53-0.12-0.36-0.840.7-0.810.090.220.15-0.2
-0.44-0.15-0.29-0.250.090.02-0.07-0.05-0.190.00.120.050.70.080.09-0.22-0.32-0.47
0.140.80.710.41-0.16-0.240.290.090.610.330.27-0.090.04-0.280.22-0.220.390.54
0.630.380.30.47-0.39-0.320.72-0.080.07-0.17-0.2-0.19-0.07-0.350.15-0.320.390.49
0.250.370.610.580.210.060.290.10.310.440.40.28-0.310.05-0.2-0.470.540.49
Click cells to compare fundamentals

PetMed Express Account Relationship Matchups

PetMed Express cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory3.5M(16.5M)2.0M13.4M(6.4M)(6.1M)
Change In Cash3.2M15.0M(7.6M)(7.0M)(48.8M)(46.4M)
Free Cash Flow36.5M37.6M16.7M22.5M(194K)(184.3K)
Change In Working Capital7.9M3.3M(9.7M)18.8M(2.8M)(2.6M)
Begin Period Cash Flow100.5M103.8M118.7M111.1M104.1M109.3M
Other Cashflows From Financing Activities(2.3M)(2.4M)(1.8M)(10.3M)(40.7M)(38.6M)
Depreciation2.3M2.4M2.7M3.5M7.1M7.4M
Other Non Cash Items191K130K165K214K324K261.8K
Capital Expenditures2.3M2.4M1.8M5.3M4.5M2.7M
Total Cash From Operating Activities38.8M40.1M18.5M27.8M4.3M4.1M
Net Income25.9M30.6M21.1M233K(7.5M)(7.1M)
Total Cash From Financing Activities(33.3M)(22.7M)(24.4M)(24.5M)(12.4M)(13.1M)
End Period Cash Flow103.8M118.7M111.1M104.1M55.3M47.6M
Total Cashflows From Investing Activities(2.3M)(2.4M)(1.8M)(10.3M)(9.2M)(8.8M)
Change To Liabilities5.7M20.6M(12.0M)6.4M7.4M7.8M
Change To Netincome2.9M3.7M4.4M5.3M6.1M6.4M
Change To Account Receivables(1.5M)1.1M509K(41K)(1.7M)(1.7M)
Stock Based Compensation2.8M3.3M4.5M6.6M6.9M7.2M
Dividends Paid21.8M22.7M24.4M24.5M12.4M19.3M
Investments(2.3M)(2.4M)(1.8M)(10.3M)(40.7M)(38.6M)
Change Receivables(1.5M)1.1M509K(41K)(47.2K)(49.5K)
Cash And Cash Equivalents Changes3.2M15.0M(7.6M)(7.0M)(8.0M)(7.6M)
Cash Flows Other Operating206K(1.9M)(85K)(1.1M)(949.5K)(902.0K)
Change To Operating Activities(973K)1.4M247K(413K)(475.0K)(451.2K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.